Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
27,754
Total Claims
$6.1M
Drug Cost
3,877
Beneficiaries
$1,566
Cost/Patient
Risk Score Breakdown 5/100
Score components are additive. Read full methodology
Peer Comparison vs. 17,757 Ophthalmology providers
+161%
Cost per patient vs peers
$1,566 vs $600 avg
+105%
Brand preference vs peers
75.0% vs 36.7% avg
Brand vs Generic
Brand: 20,827 claims · $5.7M
Generic: 6,927 claims · $349K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Cyclosporine | 1,624 | $1.5M |
| Bromfenac Sodium | 2,417 | $882K |
| Bimatoprost | 1,385 | $654K |
| Fluorometholone Acetate | 3,187 | $432K |
| Bepotastine Besilate | 1,748 | $354K |
| Lifitegrast | 347 | $262K |
| Aflibercept | 89 | $236K |
| Brimonidine Tartrate/Timolol | 880 | $214K |
| Gatifloxacin | 2,479 | $155K |
| Prednisolone Acetate | 4,047 | $150K |
| Varenicline Tartrate | 127 | $89K |
| Loteprednol Etabonate | 341 | $88K |
| Netarsudil Mesylate | 257 | $87K |
| Brimonidine Tartrate/Timolol | 454 | $76K |
| Fluorometholone | 1,148 | $74K |
Prescribing Profile
45
Unique Drugs
5.0
Anomaly Score
Patient Profile
74
Avg Age
59%
Female
1.14
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data